[HTML][HTML] Intranasal COVID-19 vaccine induces respiratory memory T cells and protects K18-hACE mice against SARS-CoV-2 infection

BK Diallo, C Ní Chasaide, TY Wong, P Schmitt, KS Lee… - npj Vaccines, 2023 - nature.com
Current COVID-19 vaccines prevent severe disease, but do not induce mucosal immunity or
prevent infection with SARS-CoV-2, especially with recent variants. Furthermore, serum …

[HTML][HTML] Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge

TY Wong, KS Lee, BP Russ, AM Horspool, J Kang… - npj Vaccines, 2022 - nature.com
SARS-CoV-2 is a viral respiratory pathogen responsible for the current global pandemic
and the disease that causes COVID-19. All current WHO approved COVID-19 vaccines are …

[HTML][HTML] SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice

KS Lee, TY Wong, BP Russ, AM Horspool, OA Miller… - Plos one, 2022 - journals.plos.org
The COVID-19 pandemic has been fueled by SARS-CoV-2 novel variants of concern (VOC)
that have increased transmissibility, receptor binding affinity, and other properties that …

[HTML][HTML] Intranasal peptide-based FpvA-KLH conjugate vaccine protects mice from Pseudomonas aeruginosa acute murine pneumonia

…, WT Witt, AC Malkowski, JR Bevere, TY Wong… - Frontiers in …, 2019 - frontiersin.org
Pseudomonas aeruginosa is an opportunistic pathogen causing acute and chronic respiratory
infections associated with morbidity and mortality, especially in patients with cystic fibrosis…

[HTML][HTML] Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis

DT Boehm, MA Wolf, JM Hall, TY Wong, E Sen-Kilic… - npj Vaccines, 2019 - nature.com
Current acellular pertussis vaccines fall short of optimal protection against the human
respiratory pathogen Bordetella pertussis resulting in increased incidence of a previously …

Longitudinal temperature measurement can determine humane endpoints in BALB/c mouse models of ESKAPEE infection

RS Dudis, TY Wong, MG Escatte, YA Alamneh… - Virulence, 2023 - Taylor & Francis
Antimicrobial resistance (AMR) is a worldwide problem, which is driving more preclinical
research to find new treatments and countermeasures for drug-resistant bacteria. However, …

Intranasal immunization with acellular pertussis vaccines results in long-term immunity to Bordetella pertussis in mice

MA Wolf, DT Boehm, MA DeJong, TY Wong… - Infection and …, 2021 - Am Soc Microbiol
Bordetella pertussis colonizes the respiratory mucosa of humans, inducing an immune
response seeded in the respiratory tract. An individual, once convalescent, exhibits long-term …

[HTML][HTML] CpG 1018® adjuvant enhances Tdap immune responses against Bordetella pertussis in mice

…, JM Hall, E Sen-Kilic, JM Blake, JE Petty, TY Wong… - Vaccine, 2022 - Elsevier
Bordetella pertussis is the causative agent of whooping cough (pertussis), a severe respiratory
disease that can be fatal, particularly in infants. Despite high vaccine coverage, pertussis …

Evaluation of adenylate cyclase toxoid antigen in acellular pertussis vaccines by using a Bordetella pertussis challenge model in mice

DT Boehm, JM Hall, TY Wong, AM DiVenere… - Infection and …, 2018 - Am Soc Microbiol
Bordetella pertussis is the primary causative agent of pertussis (whooping cough), which is
a respiratory infection that leads to a violent cough and can be fatal in infants. There is a …

Evaluating antibody mediated protection against Alpha, Beta, and Delta SARS-CoV-2 variants of concern in K18-hACE2 transgenic mice

TY Wong, AM Horspool, BP Russ, C Ye… - Journal of …, 2022 - Am Soc Microbiol
SARS-CoV-2 variants of concern (VoC) are impacting responses to the COVID-19 pandemic.
Here, we utilized passive immunization using human convalescent plasma (HCP) obtained …